181 related articles for article (PubMed ID: 27839917)
1. Discovery of new chemical entities as potential leads against Mycobacterium tuberculosis.
Lu X; Tang J; Liu Z; Li M; Zhang T; Zhang X; Ding K
Bioorg Med Chem Lett; 2016 Dec; 26(24):5916-5919. PubMed ID: 27839917
[TBL] [Abstract][Full Text] [Related]
2. Pyrazolo[1,5-a]pyridine-3-carboxamide hybrids: Design, synthesis and evaluation of anti-tubercular activity.
Lu X; Tang J; Cui S; Wan B; Franzblauc SG; Zhang T; Zhang X; Ding K
Eur J Med Chem; 2017 Jan; 125():41-48. PubMed ID: 27654393
[TBL] [Abstract][Full Text] [Related]
3. Arrival of Imidazo[2,1-b]thiazole-5-carboxamides: Potent Anti-tuberculosis Agents That Target QcrB.
Moraski GC; Seeger N; Miller PA; Oliver AG; Boshoff HI; Cho S; Mulugeta S; Anderson JR; Franzblau SG; Miller MJ
ACS Infect Dis; 2016 Jun; 2(6):393-8. PubMed ID: 27627627
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of new imidazo[2,1-b][1,3,4]thiadiazole-benzimidazole derivatives.
Ramprasad J; Nayak N; Dalimba U; Yogeeswari P; Sriram D; Peethambar SK; Achur R; Kumar HS
Eur J Med Chem; 2015 May; 95():49-63. PubMed ID: 25794789
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antitubercular evaluation of 4-carbonyl piperazine substituted 1,3-benzothiazin-4-one derivatives.
Peng CT; Gao C; Wang NY; You XY; Zhang LD; Zhu YX; Xv Y; Zuo WQ; Ran K; Deng HX; Lei Q; Xiao KJ; Yu LT
Bioorg Med Chem Lett; 2015 Apr; 25(7):1373-6. PubMed ID: 25754492
[TBL] [Abstract][Full Text] [Related]
6. Structure-based design, synthesis and biological evaluation of a newer series of pyrazolo[1,5-a]pyrimidine analogues as potential anti-tubercular agents.
Modi P; Patel S; Chhabria M
Bioorg Chem; 2019 Jun; 87():240-251. PubMed ID: 30908967
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of anti-tubercular and antibacterial activities of new 4-(2,6-dichlorobenzyloxy)phenyl thiazole, oxazole and imidazole derivatives. Part 2.
Lu X; Liu X; Wan B; Franzblau SG; Chen L; Zhou C; You Q
Eur J Med Chem; 2012 Mar; 49():164-71. PubMed ID: 22264895
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and structure-activity relationships evaluation of benzothiazinone derivatives as potential anti-tubercular agents.
Gao C; Ye TH; Wang NY; Zeng XX; Zhang LD; Xiong Y; You XY; Xia Y; Xu Y; Peng CT; Zuo WQ; Wei Y; Yu LT
Bioorg Med Chem Lett; 2013 Sep; 23(17):4919-22. PubMed ID: 23886691
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and evaluation of diarylpiperazine derivatives as potent anti-tubercular agents.
Penta A; Franzblau S; Wan B; Murugesan S
Eur J Med Chem; 2015 Nov; 105():238-44. PubMed ID: 26498570
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and investigation on the structure-activity relationships of N-substituted 2-aminothiazole derivatives as antitubercular agents.
Pieroni M; Wan B; Cho S; Franzblau SG; Costantino G
Eur J Med Chem; 2014 Jan; 72():26-34. PubMed ID: 24333612
[TBL] [Abstract][Full Text] [Related]
11. New class of methyl tetrazole based hybrid of (Z)-5-benzylidene-2-(piperazin-1-yl)thiazol-4(%H)-one as potent antitubercular agents.
Chauhan K; Sharma M; Trivedi P; Chaturvedi V; Chauhan PM
Bioorg Med Chem Lett; 2014 Sep; 24(17):4166-70. PubMed ID: 25127167
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and biological evaluation of imidazo[2,1-b]thiazole and benzo[d]imidazo[2,1-b]thiazole derivatives as Mycobacterium tuberculosis pantothenate synthetase inhibitors.
Samala G; Devi PB; Saxena S; Meda N; Yogeeswari P; Sriram D
Bioorg Med Chem; 2016 Mar; 24(6):1298-307. PubMed ID: 26867485
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of 2,4,5-trisubstituted thiazoles as antituberculosis agents effective against drug-resistant tuberculosis.
Karale UB; Krishna VS; Krishna EV; Choudhari AS; Shukla M; Gaikwad VR; Mahizhaveni B; Chopra S; Misra S; Sarkar D; Sriram D; Dusthackeer VNA; Rode HB
Eur J Med Chem; 2019 Sep; 178():315-328. PubMed ID: 31195172
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, in vitro and in silico studies of 2, 3-diaryl benzofuran derivatives as antitubercular agents.
Bhukya B; Shukla A; Chaturvedi V; Trivedi P; Kumar S; Khan F; Negi AS; Srivastava SK
Bioorg Chem; 2020 Jun; 99():103784. PubMed ID: 32361184
[TBL] [Abstract][Full Text] [Related]
15. 2,3-dideoxy hex-2-enopyranosid-4-uloses as promising new anti-tubercular agents: design, synthesis, biological evaluation and SAR studies.
Saquib M; Husain I; Sharma S; Yadav G; Singh VK; Sharma SK; Shah P; Siddiqi MI; Kumar B; Lal J; Jain GK; Srivastava BS; Srivastava R; Shaw AK
Eur J Med Chem; 2011 Jun; 46(6):2217-23. PubMed ID: 21440336
[TBL] [Abstract][Full Text] [Related]
16. Preclinical comprehensive physicochemical and pharmacokinetic profiling of novel nitroimidazole derivative IIIM-019 - A potential oral treatment for tuberculosis.
Kour G; Kumar A; Singh PP; Sharma S; Bhagat A; Vishwakarma RA; Ahmed Z
Pulm Pharmacol Ther; 2016 Oct; 40():44-51. PubMed ID: 27457685
[TBL] [Abstract][Full Text] [Related]
17. Pyrazole clubbed triazolo[1,5-a]pyrimidine hybrids as an anti-tubercular agents: Synthesis, in vitro screening and molecular docking study.
Bhatt JD; Chudasama CJ; Patel KD
Bioorg Med Chem; 2015 Dec; 23(24):7711-6. PubMed ID: 26631439
[TBL] [Abstract][Full Text] [Related]
18. Benzo[d]thiazole-2-carbanilides as new anti-TB chemotypes: Design, synthesis, biological evaluation, and structure-activity relationship.
Dhameliya TM; Tiwari R; Banerjee A; Pancholia S; Sriram D; Panda D; Chakraborti AK
Eur J Med Chem; 2018 Jul; 155():364-380. PubMed ID: 29902722
[TBL] [Abstract][Full Text] [Related]
19. Physicochemical, pharmacokinetic, efficacy and toxicity profiling of a potential nitrofuranyl methyl piperazine derivative IIIM-MCD-211 for oral tuberculosis therapy via in-silico-in-vitro-in-vivo approach.
Magotra A; Sharma A; Singh S; Ojha PK; Kumar S; Bokolia N; Wazir P; Sharma S; Khan IA; Singh PP; Vishwakarma RA; Singh G; Nandi U
Pulm Pharmacol Ther; 2018 Feb; 48():151-160. PubMed ID: 29174840
[TBL] [Abstract][Full Text] [Related]
20. Discovery of thienothiazolocarboxamide analogues as novel anti-tubercular agent.
Jin G; Mi Kim Y; Lee A; Choi J; Kang S; Seo M; Jea Seo J; Lee S; Kang J; Kim J; Park S; Woo M; Falcão VCA; Lee H; Heo J; Shum D; Park K; Delorme V; Choi I
Bioorg Med Chem; 2020 Dec; 28(23):115797. PubMed ID: 33075682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
